Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$8.35 - $21.89 $4,175 - $10,945
-500 Closed
0 $0
Q1 2022

Apr 14, 2022

BUY
$16.97 - $31.93 $8,485 - $15,965
500 New
500 $10,000
Q4 2019

Feb 06, 2020

SELL
$13.12 - $17.06 $3,935 - $5,118
-300 Closed
0 $0
Q3 2019

Oct 28, 2019

SELL
$12.75 - $19.01 $1,275 - $1,901
-100 Reduced 25.0%
300 $4,000
Q2 2019

Aug 09, 2019

BUY
$17.0 - $21.88 $3,400 - $4,376
200 Added 100.0%
400 $7,000
Q1 2019

May 10, 2019

SELL
$15.53 - $22.15 $1,553 - $2,215
-100 Reduced 33.33%
200 $4,000
Q4 2018

Feb 05, 2019

BUY
$14.06 - $22.57 $4,218 - $6,771
300 New
300 $5,000
Q3 2018

Nov 07, 2018

SELL
$13.35 - $19.1 $1,335 - $1,910
-100 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$10.35 - $16.45 $1,035 - $1,645
100 New
100 $1,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.